Late-gadolinium enhancement on CMR is associated with adverse clinical outcomes and determines remodelling in heart failure patients treated with sacubitril/valsartan: a retrospective study
29 June 2021 (00:00 - 00:00)
Organised by:
About the speaker

University Hospitals of Coventry and Warwickshire NHS Trust, Coventry (United Kingdom of Great Britain & Northern Ireland)
738 More presentations in this session
Assistant Professor N. Radovanovic (Belgrade, RS)
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Access the full session
The Event
Heart Failure 2021
29 June - 1 July 2021
You may be interested in
Congress Presentation

